Plant-based coronavirus vaccine shows ‘positive efficacy and safety results,’ developers say

Pharmaceutical company GlaxoSmithKline (GSK) on Tuesday announced positive results from a phase three trial of its plant-based coronavirus vaccine, the first inoculant of its kind to reach a stage to seek emergency approval.The vaccine has an…